DOCSLIB.ORG

Langerhans Cell (Eosinophilic) Granulomatosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Langerhans Cell (Eosinophilic) Granulomatosis 0022-202X/ 80/ 750 1-0071$02.00/ 0 THE JouRNAL o~- INvESTIGATIVE DERMA'l'OLOGY, 75:71-72, 1980 Vol. 75, No. I Copyright © 1980 by The Williams & Wilkins Co. Printed in U. S.A. Lang~rhans Cell (Eosinophilic) Granulomatosis PHILIP H. LIEBERMAN, M.D., CHARLES RAY JONES, M.D., AND DANIEL A. FILIPPA, M.D. Surgical Pathology Service and Department of Pediatrics, M emorial Hospital for Cancer and Allied Diseases, N ew York, N ew York, U.S.A. Eosinophilic granuloma (Langerhans cell granuloma­ neoplasms characterized principally by the presence of histio­ tosis) is the only basically nondermatological disorder cytic elements. consistently associated with the Langerhans cell. Its clin­ ical manifestations are protean. There is much circum­ CLINICAL ASPECTS OF EOSINOPHILIC stantial evidence to suggest that this disease is funda­ (LANGERHANS CELL) GRANULOMAS [13] mentally immunologic. This is consistent with current Eosinophilic granuloma is a disorder readily recognizable by concepts about the Langerhans cell. light microscopy. It is found either in a unifocal or multifocal state and consists of admixtures of eosinophils and mononuclear cells (the latter cells in large part are Langerhans cells). Varying In view of the enormous body of dermatological literature degrees of necrosis and fibrosis are present, as well as multi­ concerning the Langerhans cell [1-4], it is not smprising that nucleated giant cells and foamy histiocytes; the latter are pres­ most of the pathologic changes related to these cells are found ent especially in areas of suppuration. Healing of the lesions is in skin disorders. It was of great interest, therefore, when Basset by fibrosis. The classical sites for the granulomas are bones, but and Turiaf [5] described in 1965 the presence of Langerhans soft tissues such as skin, gingiva, lymph nodes (Fig. 1) , and lung cells in "histiocytosis X" of the lung. Since that discovery, the may be involved. Most of the statistical facts about the disease presence of Langerhans cells (identified by the presence of are derived from bone cases since the lesions are most com­ Birbeck granules [6]) has been found in a host of disorders­ monly found in bone. Symptoms in unifocal cases are pain and primarily dermatological, occasionally lymph nodal, rarely neo­ swelling; fractmes are not uncommon. Multifocal lesions may plastic [7]. Most of the instances in which Langerhans cells include various bony sites, lymph nodes, and lungs. Many have been found in human lymph nodes have involved persons patients have otitis externa, otitis media, and mastoiditis (note with reactive nodes, e.g., with dermatopathic lymphadenitis the relationship to squamous epithelium). Ulcerating gingival and subacute sclerosing panencephalitis. Only one nonderma­ lesions and loosening of teeth are not uncommon. Patients with tological disease process has been consistently linked to the multifocal eosinophilic granuloma may have protracted ill­ Langerhans cell, and that is eosinophilic granuloma. Indeed, nesses, with recrudescence of lesions, fever, and organomegaly since the Langerhans cell is the most important feature of for many years. eosinophilic granuloma, rather than the eosinophil itself, it The prognosis is very good, especially if appropriate and might not be amiss to take Dr. Wolffs suggestion and rename modest therapeutic measures are taken by physicians skilled in the process "Langerhans cell granulomatosis" [2]. treating these patients. Orthopedic, dental, or pulmonary prob­ lems often mar the recovery state. Diabetes insipidus, probably CLARIFICATION OF TERMINOLOGY due to granulomatous involvement of the hypothalamic area, is The study of eosinophilic granuloma has been complicated often transient, but occasionally may be permanent. by a complex jargon. Histiocytosis X, or more recently histio­ Laboratory findings have been disappointing. Despite the cytosis, refers to a spectrum of diseases encompassing both the great incidence of allergic histories, tests of cellular and non­ benign disorder, eosinophilic granuloma, and malignant lym­ cellular immunity have been unrewarding. Parasitic and bac­ phomatous diseases [8]. We have challenged this concept on terial. agents have not been found to be clinically important. clinical, historical, and histological grounds [9]. Hand-Schi.iller­ Christian disease has been redefined over the years and, as used today, is probably synonymous with multifocal eosinophilic granuloma. Letterer-Siwe syndrome (disease) as formally de­ fined by Abt and Denenholz [10) is characterized by (a) hepa­ tosplenomegaly, (b) hemorrhagic diathesis, (c) lymphadenop~­ thy, (d) localized tumefactions over bones, (e) secondary anemia and normal differential and platelet counts, (0 increased num­ bers of non-lipid-containing macrophages in the splenic aspi­ rate, (g) no familial or hematological disposition, (h) ~ccurr~nce exclusively in infants, (i) acute onset, unrelated to mfectwns, and a downhill course for weeks to several years, (j) unknown etiology, and (k) generalized hyperplasia of non-lipid-containing macrophages in various organs. The redefinition of these non­ specific criteria by various investigators has caused much con­ fusion. The terms reticuloendotheliosis and reticulosts are also unsuitable for modern usage, as discussed elsewhere [11]. If we eliminate infectious disorders, nonspecific case reports, hemo­ phagocytic reticulosis probably due to maternal hematopoietic grafts [12], graft-versus-host disease, and combined immuno­ deficiency syndromes, we are left with a group of malignant Reprint requests to: Philip Lieberman, M.D., Surgical Pathology Service, Memorial Hospital for Cancer and Allied Diseases, New York, FrG I. Langerhans cell granulomatosis involving lymph node (he­ New York 10021. matoxylin and eosin, reduced from X 630). 71 72 LIEBERMAN, JONES, AND FILIPPA Vol. 75, No. 1 conditions in which eosinophils are a prominent featUJ·e but Langerhans cells are lacking. Eosinophilic cystitis, enteritis, and lymphadenitis are often confused with this disorder. ETIOLOGY The pathogenesis of eosinophilic granuloma is unknown. In almost all cases of eosinophilic granuloma, it has been possible to identify the Langerhans cell by electron microscopy. The characteristic Birbeck granules in this disorder seem to arise from the plasmalemma (Fig 2). It is possible the Bii·beck granules represent structural membrane alterations secondary to antigenic challenge. The presence ofLangerhans cells (Fig 3) [14,15], eosinophilia, a high frequency of allergic backgrounds, and the response of the lesions to therapeutic agents used both clinically and experimentally to suppress eosinophilia all sug­ gest that the disease is reactive rather than neoplastic and may have an immunologic basis. REFERENCES 1. Breathnach AS: The cell of Langerhans. Int Rev Cytol 18:1-28, FIG 2. Electron micrograph showing a Langerhans cell from a per­ 1965 son with Langerhans cell granulomatosis. Arrow indicates a Birbeck 2. Wolff K: The Langerhans cell. Curr Probl Derma tot 4:79-145, 1972 granule (reduced from X 10,800). Inset, Birbeck granule (reduced from 3. Riley P A: The Langerhans cell, The Physiology and Pathophysi­ X 128,000). ology of the Skin. Edited by A Jarrett. New York, Academic Press, 1974, pp 1199-1218 4. Shelley WB, Juhlin L: The Langerhans cell: Its origin, nature and function. Acta Derm Venereol [Suppl 79] (Stockh) 58:7-22, 1978 5. Basset F, Tw·iaf J: Identification par Ia microscopic electronique de particules de nature probablement virale dans les lesions granulomateuses d'une histiocytose-X pulmonaire. C R Acad Sci . .. (Paris) 261:3701-3703, 1965 ' 6. Birbeck MSC, Breathnach AS, Everall JD: An electron microscopic .. .. study of basal melanocyte and high level clear cell (Langerhans ... cell) in vitiligo. J Invest Dermatol 37:51- 63, 1961 . 7. Vernon ML, Fountain L, KJ·ebs HM, Horta-Bru·bosa L, Fuccillo DA, Sever JL: Birbeck granules (Langerhans' cell granules) in human lymph nodes. Am J Clin Pathol 60:771-779, 1973 8. Lichtenstein L: Histiocytosis X. Integration of eosinophilic granu­ loma of bone, "Letterer-Siwe disease," and "Schi.iller-Christian , disease" as related manifestations of a single nosologic entity. ,t Arch Pathol 56:84- 102, 1953 9. Lieberman PH, Jones CR, Dru·geon HWK, Begg CF: A reappraisal of eosinophilic granuloma of bone, Hand-Schi.iller-Christian syn­ drome and Letterer-Siwe syndrome. Medicine 48:375-400, 1969 • 10. Abt AF, Denenholz EJ: Letterer-Siwe's disease. Splenohepatome­ • galy associated with widespread hyperplasia of nonlipoid storing ' macrophages; discussion of the so-called reticuloendothelioses. I' Am J Dis Child 51:499-522, 1936 I 11. Symmers WSC: The lymphoreticular system, Systemic Pathology vol I. Edited by GP Wright, WSC Symmers. London, Longmans: Green and Company, 1966, pp 195-274 12. Blennow G, Berg B, Brandt L, Messeter L, Low B, Soderstrom N: FIG 3. Dendritic ATPase-positive ceLls cu.l tured from a person with Haemophagocytic reticulosis. A state of chimerism? Arch Dis Langerhans cell granulomatosis. Courtesy of Drs. K. Lele and G. Potter Child 49:960-962, 1974 (reduced from x 450). 13. Lieberman PH: Eosinophilic granuloma and related synd.J·omes Cecil Textbook of Medicine, 15th edition, section 8. Edited by PB Beeson, W McDermott, JB Wyngaru·den. Philadelphia, WB Viral studies, particularly studies on slow virus infections, have Saunders Company, 1979, pp 1848-1851 been woefully lacking. 14. Silberberg-Sinakin I, Baer RL, Thorbecke GJ: Langerhans cells. A review of their nature with emphasis on their immunologic func­ IMPROPER USE OF THE TERM EOSINOPHILIC tions. Prog Allergy 24:268-294, 1978 GRANULOMA 15. Sting! G, Katz SI, Shevach EM, Rosenthal AS, Green I: Analogous functions of macrophages and Langerhans cells in the initiation Many pathologists use the term eosinophilic granuloma for of the immune response. J Invest Derma to! 71:59-64, 1978 .
Load more

Recommended publications
  • Regulation of Macrophage Development and Function in Peripheral Tissues
    REVIEWS Regulation of macrophage development and function in peripheral tissues Yonit Lavin, Arthur Mortha, Adeeb Rahman and Miriam Merad Abstract | Macrophages are immune cells of haematopoietic origin that provide crucial innate immune defence and have tissue-specific functions in the regulation and maintenance of organ homeostasis. Recent studies of macrophage ontogeny, as well as transcriptional and epigenetic identity, have started to reveal the decisive role of the tissue stroma in the regulation of macrophage function. These findings suggest that most macrophages seed the tissues during embryonic development and functionally specialize in response to cytokines and metabolites that are released by the stroma and drive the expression of unique transcription factors. In this Review, we discuss how recent insights into macrophage ontogeny and macrophage–stroma interactions contribute to our understanding of the crosstalk that shapes macrophage function and the maintenance of organ integrity. Mononuclear phagocyte Macrophages are key components of the innate immune characterized the transcriptional and epigenetic pro- system system that reside in tissues, where they function as grammes of tissue-resident macrophages and revealed (MPS). A group of bone immune sentinels. They are uniquely equipped to sense the extent of diversity in these populations1,8. In addi- marrow-derived cells and respond to tissue invasion by infectious microorgan- tion to differences in ontogeny, locally derived tissue (monocytes, macrophages and isms and tissue
    [Show full text]
  • A Single Wave of Monocytes Is Sufficient to Replenish the Long-Term
    bioRxiv preprint doi: https://doi.org/10.1101/617514; this version posted April 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A single wave of monocytes is sufficient to replenish the long-term Langerhans cell network after immune injury Ivana R. Ferrer1,2,a, Heather C. West1,2,a, Stephen Henderson2, Dmitry S. Ushakov3, Pedro Santos e Sousa1,2, Jessica Strid4, Ronjon Chakraverty1,2, Andrew J. Yates5, and Clare L. Bennett1,2 1Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK 2Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK. 3Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, New Hunt’s House, Newcomen St, London SE1 1UL, UK 4Division of Immunology and Inflammation, Imperial College London, Hammersmith campus, London W12 0NN, UK. 5Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY10032, USA. aThese authors contributed equally to this work Abstract • Immune injury and inefficient repopulation by Embryo-derived Langerhans cells (eLC) are maintained within monocyte-derived cells lead to a permanently altered the sealed epidermis without contribution from circulating cells. LC niche. When the network is perturbed by transient exposure to ultra- violet light, short-term LC are temporarily reconstituted from an initial wave of monocytes, but thought to be superseded by more permanent repopulation with undefined LC precur- sors. However, the extent to which this mechanism is relevant to immune-pathological processes that damage LC population integrity is not known.
    [Show full text]
  • Progress in Understanding the Pathogenesis of Langerhans Cell Histiocytosis: Back to Histiocytosis X?
    review Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Marie-Luise Berres,1,2,3,4 Miriam Merad1,2,3 and Carl E. Allen5,6 1Department of Oncological Sciences, Mount Sinai School of Medicine, 2Tisch Cancer Institute, Mount Sinai School of Medicine, 3Immunology Institute, Mount Sinai School of Medicine, New York, NY, USA, 4Department of Internal Medicine III, University Hospital, RWTH Aachen, Aachen, Germany, 5Texas Children’s Cancer Center, and 6Baylor College of Medicine, Houston, TX, USA Summary Langerhans cell histiocytosis (LCH) is the most common his- tiocytic disorder, arising in approximately five children per Langerhans cell histiocytosis (LCH), the most common million, similar in frequency to paediatric Hodgkin lym- histiocytic disorder, is characterized by the accumulation of phoma and acute myeloid leukaemia (AML) (Guyot-Goubin CD1A+/CD207+ mononuclear phagocytes within granuloma- et al, 2008; Stalemark et al, 2008; Salotti et al, 2009). The tous lesions that can affect nearly all organ systems. Histori- median age of presentation is 30 months, though LCH is cally, LCH has been presumed to arise from transformed or reported in adults in approximately one adult per million, pathologically activated epidermal dendritic cells called Lan- both as unrecognized chronic paediatric disease and de novo gerhans cells. However, new evidence supports a model in disease (Baumgartner et al, 1997). There are occasional which LCH occurs as a consequence of a misguided differen- reports of affected non-twin siblings and multiple cases in tiation programme of myeloid dendritic cell precursors. one family, though it is not clear if this is significantly more Genetic, molecular and functional data implicate activation frequent than one would expect by chance (Arico et al, of the ERK signalling pathway at critical stages in myeloid 2005).
    [Show full text]
  • Epidermal Macrophage Induction, and Langerhans Cell Depletion (Photoimmunology/Ozone Depletion/Contact Sensitivity/T Lymphocytes/Antigen Presenting Cells) K
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 8497-8501, September 1992 Immunology UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: Relationship to dose, CDla-DR+ epidermal macrophage induction, and Langerhans cell depletion (photoimmunology/ozone depletion/contact sensitivity/T lymphocytes/antigen presenting cells) K. D. COOPER*t*, L. OBERHELMAN*, T. A. HAMILTON*, 0. BAADSGAARD*§, M. TERHUNE*, G. LEVEE*, T. ANDERSON*t, AND H. KOREN¶ *Immunodermatology Unit, Department of Dermatology, University of Michigan, Ann Arbor, MI 48109; tVeterans Administration Hospital, Ann Arbor, MI 48105; and 'Health Effects Research Labs, Environmental Protection Agency, Chapel Hill, NC 27711 Communicated by Thomas M. Donahue, May 1, 1992 ABSTRACT Increasing UVB radiation at the earth's sur- tibility of UV-exposed mice and the unresponsiveness of face might have adverse effects on in vivo immunologic responses UV-exposed mice to contact allergens were found to be due in humans. We prospectively randomized subjects to test to antigen-specific suppressor T lymphocytes (12, 13). whether epicutaneous immunization is altered by prior admin- UV regulation of murine contact sensitivity has held up istration of biologically equalized doses of UV radiation. Mul- well as a model of immunologic events occurring in photo- tiple doses of antigens on upper inner arm skin (UV protected) carcinogenesis. Epidermal Langerhans cells, an antigen pre- were used to elicit contact sensitivity responses, which were senting population of dendritic cell lineage present in the quantitated by measuring increases in skin thickness. If a dose epidermis (14), have a potent capacity to initiate contact of UVB sufficient to induce redness (erythemagenic) was ad- sensitivity reactions (15, 16), as well as tumor rejection (17).
    [Show full text]
  • Langerhans Cell Langhans Cell
    1 Q Ocular-Surface Immunology The names of these two cell types are easily confused—what are they? This one is: --A type of dendritic cell residing in the ocular surface epithelium --An antigen-presenting cell (APC) --Described as the ‘immune sentinels of the ocular surface’ Langerhans cell This one is: --A type of giant cell found in granulomas --Associated with TB --Horseshoe-like arrangement of nuclei Langhans cell 2 A Ocular-Surface Immunology The names of these two cell types are easily confused—what are they? This one is: --A type of dendritic cell residing in the ocular surface epithelium --An antigen-presenting cell (APC) --Described as the ‘immune sentinels of the ocular surface’ Langerhans cell This one is: --A type of giant cell found in granulomas --Associated with TB --Horseshoe-like arrangement of nuclei Langhans cell 3 Ocular-Surface Immunology The names of these two cell types are easily confused—what are they? This one is: --A type of dendritic cell residing in the ocular surface epithelium --An antigen-presenting cell (APC) --Described as the ‘immune sentinels of the ocular surface’ Langerhans cell The … This one is: ER --A type of giant cell found in granulomas --Associated with TB --Horseshoe-like arrangement of nuclei Langhans cell 4 Ocular-Surface Immunology The names of these two cell types are easily confused—what are they? This one is: --A type of dendritic cell residing in the ocular surface epithelium --An antigen-presenting cell (APC) --Described as the ‘immune sentinels of the ocular surface’ Langerhans cell
    [Show full text]
  • Congenital Self-Healing Reticulohistiocytosis: an Underreported Entity
    Congenital Self-healing Reticulohistiocytosis: An Underreported Entity Michael Kassardjian, DO; Mayha Patel, DO; Paul Shitabata, MD; David Horowitz, DO PRACTICE POINTS • Langerhans cell histiocytosis (LCH) is believed to occur in 1:200,000 children and tends to be underdiagnosed, as some patients may have no symptoms while others have symptoms that are misdiagnosed as other conditions. • Patients with L CH usually should have long-term follow-up care to detect progression or complications of the disease or treatment. copy not Langerhans cell histiocytosis (LCH), also known angerhans cell histiocytosis (LCH), also as histiocytosis X, is a group of rare disorders known as histiocytosis X, is a general term that characterized by the continuous replication of describes a group of rare disorders characterized L 1 a particular white blood cell called LangerhansDo by the proliferation of Langerhans cells. Central cells. These cells are derived from the bone mar- to immune surveillance and the elimination of for- row and are found in the epidermis, playing a large eign substances from the body, Langerhans cells are role in immune surveillance and the elimination of derived from bone marrow progenitor cells and found foreign substances from the body. Additionally, in the epidermis but are capable of migrating from Langerhans cells are capable of migrating from the the skin to the lymph nodes. In LCH, these cells skin to lymph nodes, and in LCH, these cells begin congregate on bone tissue, particularly in the head to congregate on the bone, particularly in the head and neck region, causing a multitude of problems.2 and neck region, causingCUTIS a multitude of problems.
    [Show full text]
  • Patterning Langerhans Cell Proliferation and Rsk Signaling
    The Journal of Immunology The PDK1–Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning Rossana Zaru,*,1 Stephen P. Matthews,* Alexander J. Edgar,* Alan R. Prescott,* Diego Gomez-Nicola,† Andre´ Hanauer,‡ and Colin Watts* Langerhans cells (LC), the dendritic cells of the epidermis, are distributed in a distinctive regularly spaced array. In the mouse, the LC array is established in the first few days of life from proliferating local precursors, but the regulating signaling pathways are not fully understood. We found that mice lacking the kinase phosphoinositide-dependent kinase 1 selectively lack LC. Deletion of the phosphoinositide-dependent kinase 1 target kinases, ribosomal S6 kinase 1 (Rsk1) and Rsk2, produced a striking perturbation in the LC network: LC density was reduced 2-fold, but LC size was increased by the same magnitude. Reduced LC numbers in Rsk1/22/2 mice was not due to accelerated emigration from the skin but rather to reduced proliferation at least in adults. Rsk1/2 were required for normal LC patterning in neonates, but not when LC were ablated in adults and replaced by bone marrow– derived cells. Increased LC size was an intrinsic response to reduced LC numbers, reversible on LC emigration, and could be observed in wild type epidermis where LC size also correlated inversely with LC density. Our results identify a key signaling pathway needed to establish a normal LC network and suggest that LC might maintain epidermal surveillance by increasing their “footprint” when their numbers are limited. The Journal of Immunology, 2015, 195: 4264–4272. mmune surveillance in the skin is mediated by different The mechanisms behind LC development have been the subject of dendritic cell (DC) populations including Langerhans cells intense recent investigation.
    [Show full text]
  • Abstract Introduction Case Synopsis
    Volume 22 Number 4 April 2016 Case report Congenital cutaneous Langerhans cell histiocytosis and cutaneous mastocytoma in a child B Lozano Masdemont MD1, M Campos Domínguez MD PhD1, L Gómez-Recuero Muñoz MD1, B Moreno García MD2 , V Parra Blanco MD3, R Suárez Fernández MD PhD1 Dermatology Online Journal 22 (4): 3 1Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 2Department of Ophthalmology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 3Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain Correspondence: Belén Lozano Masdemont Department of Dermatology , Hospital General Universitario Gregorio Marañón, Dr Esquerdo st, 46, 28007, Madrid, Spain. Phone/ Fax: +34 91 586 66 80 Email: [email protected] Abstract Langerhans cell histiocytosis and mastocytoma are clonal disorders of bone-marrow-derived cells, most commonly seen in the pediatric age. Infiltration of mast cells and Langerhans cells in the same lesion has been published before, but, to our knowledge, this is the first time that the occurrence of two mastocytomas and Langerhans cell histiocytosis is reported. It could be hypothesized that both clonal disorders of bone-marrow-derived cells could have a common origin. Keywords: Langerhans cell histiocytosis, mastocytoma, mastocytosis, neonate. Introduction Langerhans cell histiocytosis is a proliferation of immature myeloid dendritic cells, with a broad clinical spectrum from isolated skin lesions to multisystem life-threatening disease. Mastocytomas are a common type of cutaneous mastocytosis, which generally appear in the first year of life and resolve during childhood. Both are clonal disorders of bone-marrow-derived cells, most commonly seen in the pediatric age. The occurrence of two mastocytomas and Langerhans cell histiocytosis has never been described.
    [Show full text]
  • Granulocytes
    Stockholm, Sweden, June 13–16, 2013 Granulocytes P1024 LIPEGFILGRASTIM–A LONG-ACTING, ONCE-PER-CYCLE, GLYCOPEGY - LATED RECOMBINANT HUMAN FILGRASTIM CREATED WITH SITE-SPE - P1022 CIFIC GLYCOPEGYLATION TECHNOLOGY C Scheckermann 1,* , K Schmidt 1, A Abdolzade-Bavil 1, H Allgaier 2, U Mueller 3, IMMUNOGENICITY OF LIPEGFILGRASTIM AND PEGFILGRASTIM IN W Shen 4, P Liu 5 BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY: INTEGRAT - 1BioGeneriX GmbH, 2Merckle Biotec GmbH, 3Teva GmbH, Ulm, Germany, ED ANALYSIS FROM PHASE II AND III STUDIES 4Teva Pharmaceuticals, West Chester, 5Teva Pharmaceuticals, Washington A Abdolzade-Bavil 1,* , L Zou 2, C Sadhu 3, A Buchner 4, P Liu 3 DC, United States 1BioGeneriX GmbH, Ulm, Germany, 2Teva Pharmaceuticals, Rockville, 3Teva Biopharmaceuticals, Washington DC, United States, 4Teva ratiopharm, Ulm, Background: Lipegfilgrastim is a once-per-cycle, fixed-dose glycoPEGylated Germany granulocyte-colony stimulating factor (G-CSF) under development for the preven - tion of severe neutropenia in cancer patients receiving chemotherapy (CTx). Tra - Background: Lipegfilgrastim is a novel, long-acting, fixed-dose, glycoPEGy - ditional PEGylation of biologic molecules has been used successfully for more lated recombinant granulocyte-colony stimulating factor (rG-CSF) under review than 10 years to extend the half-life in the body, requiring less frequent dosing for neutropenia prevention in patients receiving myelosuppressive chemother - and allowing for the administration of G-CSF once per CTx cycle, making treat - apy (CTx) for cancer. Like any biological product, lipegfilgrastim could poten - ment potentially less expensive and enhancing patient compliance and safety. tially elicit an anti-drug antibody (ADA) response, which could cause adverse However, the traditional PEGylation use of chemical conjugation through reac - events (AEs) or lack of efficacy.
    [Show full text]
  • Targeting Epidermal Langerhans Cells by Epidermal Powder Immu- Nization
    Cell Research (2002); 12(2):97-104 http://www.cell-research.com REVIEW Targeting epidermal Langerhans cells by epidermal powder immu- nization DEXIANG CHEN*, LENDON G PAYNE PowderJect Vaccines, Inc. 585 Science Drive, Madison, WI 53711, USA ABSTRACT Immune reactions to foreign or self-antigens lead to protective immunity and, sometimes, immune disorders such as allergies and autoimmune diseases. Antigen presenting cells (APC) including epidermal Langerhans cells (LCs) play an important role in the course and outcome of the immune reactions. Epider- mal powder immunization (EPI) is a technology that offers a tool to manipulate the LCs and the potential to harness the immune reactions towards prevention and treatment of infectious diseases and immune disorders. Key words: Langerhans cells, dendritic cells, vaccines, epidermal immunization. THE BIOLOGY OF LANGERHANS CELLS bone marrow progenitor cells, which travel through LCs, like the related dendritic cells (DCs), are blood to home in the epidermis and become LCs[6- professional antigen presenting cells. LCs are 8]. Cytokines such as interleukin-4 (IL-4), tumor- α uniquely present in the epidermis of the skin while necrosis factora (TNF- ), and granulocyte macroph- DCs are present in the mucosa, dermis, and inter- age colony stimulating factor (GM-CSF) are thought nal organs. Epidermal LCs form a semi-continuous to drive the differentiation process of the progenitor network in the skin. The density of LCs in most cells[9]. The resident LCs in the epidermis are im- areas of the human skin with the exception of sole mature cells possessing strong phagocytic and and palm is approximately 500-1000 cells/mm2 (an endocytic capacity.
    [Show full text]
  • Langerhans Cell Migration in Vivo Ige-Mediated Mast Cell Activation
    IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo Dunia M. Jawdat, Eric J. Albert, Geoffrey Rowden, Ian D. Haidl and Jean S. Marshall This information is current as of September 26, 2021. J Immunol 2004; 173:5275-5282; ; doi: 10.4049/jimmunol.173.8.5275 http://www.jimmunol.org/content/173/8/5275 Downloaded from References This article cites 48 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/173/8/5275.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo1 Dunia M. Jawdat, Eric J. Albert, Geoffrey Rowden, Ian D. Haidl, and Jean S. Marshall2 Langerhans cells and mast cells are both resident in large numbers in the skin and act as sentinel cells in host defense.
    [Show full text]
  • Ch33 WO Pt1.Pdf
    33 Innate Host Resistance 1 33.1 Innate Resistance Overview 1. Identify the major components of the mammalian host immune system 2. Integrate the major immune components and their functions to explain in general terms how the immune system protects the host 2 Host Resistance Overview • Most pathogens (disease causing microbes) – must overcome surface barriers and reach underlying – overcome resistance by host • nonspecific resistance • specific immune response 3 Host Resistance Overview… • Immune system – composed of widely distributed cells, tissues, and organs – recognizes foreign substances or microbes and acts to neutralize or destroy them • Immunity – ability of host to resist a particular disease or infection • Immunology – science concerned with immune responses 4 Immunity • Nonspecific immune response – Aka nonspecific resistance, innate, or natural immunity – acts as a first line of defense – offers resistance to any microbe or foreign material – lacks immunological memory • Specific immune response – Aka acquired, adaptive, or specific immunity – resistance to a particular foreign agent – has “memory” • effectiveness increases on repeated exposure to agent 5 6 Antigens • Recognized as foreign • Invoke immune responses – presence of antigen in body ultimately results in B cell activation production of antibodies • antibodies bind to specific antigens, inactivating or eliminating them • other immune cells also become activated • Name comes from antibody generators 7 White Blood Cells of Innate and Adaptive Immunity • White blood
    [Show full text]